Search results
AstraZeneca PLC (OTCMKTS:AZNCF) Sees Large Drop in Short Interest
ETF DAILY NEWS· 1 day agoAstraZeneca PLC (OTCMKTS:AZNCF – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 31st, there was short interest ...
Why AstraZeneca plc (NASDAQ:AZN) is Investors’ One of Favorite International Dividend Stock?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since AstraZeneca ...
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks· 1 day agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic control in patients aged 10 years and older with T2D. It was previously approved for such use in adults.
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 4 days agoAstraZeneca PLC (NASDAQ:AZN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering ...
Ethic Inc. Grows Stake in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 2 days agoEthic Inc. lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 10.7% in the 4th quarter, according to its most recent 13F filing ...
AstraZeneca CEO gifts shares to family, no sale involved By Investing.com
Investing.com· 2 days agoAstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN) disclosed in a recent regulatory filing with the...
AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
Yahoo Finance· 22 hours agoAstraZeneca (AZN) has long been in the oncology and other disease spaces, but rose to popularity in...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe US Food and Drug Administration (FDA) has granted approval for AstraZeneca's Farxiga...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Market Watch· 2 days agoPublished: June 12, 2024 at 6:01 p.m. ETShareResizeBy Ben GlickmanAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children ...
Insmed retains rights to brensocatib after talks with AstraZeneca end By Investing.com
Investing.com· 22 hours agoInsmed (NASDAQ:INSM) Incorporated, a pharmaceutical company based in Bridgewater, New Jersey,...